{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:45:30Z","timestamp":1764920730739,"version":"3.46.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rmed.2025.108187","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:43:56Z","timestamp":1748720636000},"page":"108187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of nebulised tranexamic acid in adult patients with cystic fibrosis: A retrospective audit"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8223-0090","authenticated-orcid":false,"given":"Alison","family":"Merchant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raynuka","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-4941","authenticated-orcid":false,"given":"Peter G.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108187_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejpb.2015.04.015","article-title":"Inhalable tranexamic acid for haemoptysis treatment","volume":"93","author":"Haghi","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.rmed.2025.108187_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/resp.12764","article-title":"Physiotherapy for cystic fibrosis in Australia and New Zealand: a clinical practice guideline","volume":"21","author":"Button","year":"2016","journal-title":"Respirology (Carlton South)"},{"issue":"4","key":"10.1016\/j.rmed.2025.108187_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.prrv.2012.01.003","article-title":"Cystic fibrosis: management of haemoptysis","volume":"13","author":"Hurt","year":"2012","journal-title":"Paediatr. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108187_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chest.2019.07.012","article-title":"Managing massive hemoptysis","volume":"157","author":"Davidson","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.108187_bib6","first-page":"17","article-title":"Approaches to the management of haemoptysis in young people with cystic fibrosis","volume":"46","author":"Sheppard","year":"2023","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108187_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2016.07.006","article-title":"Efficacy of tranexamic acid in haemoptysis: a randomized, controlled pilot study","volume":"40","author":"Bellam","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.rmed.2025.108187_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/LBR.0b013e3181dc8c17","article-title":"Endobronchial administration of tranexamic acid for controlling pulmonary bleeding: a pilot study","volume":"17","author":"M\u00e1rquez-Mart\u00edn","year":"2010","journal-title":"J. Bronchology Interv. Pulmonol."},{"issue":"8","key":"10.1016\/j.rmed.2025.108187_bib9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.rmed.2009.02.004","article-title":"Pulmonary hemorrhage: a novel mode of therapy","volume":"103","author":"Solomonov","year":"2009","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108187_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.chest.2015.10.016","article-title":"Inhaled tranexamic acid as an alternative for hemoptysis treatment","volume":"149","author":"Segrelles Calvo","year":"2016","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2025.108187_bib11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/jpm.2015.0167","article-title":"Nebulized tranexamic acid as a noninvasive therapy for cancer-related hemoptysis","volume":"18","author":"Hankerson","year":"2015","journal-title":"J. Palliat. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108187_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.02.348","article-title":"Inhaled tranexamic acid: an alternative treatment for active hemoptysis","volume":"155","author":"Ng","year":"2019","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108187_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5144\/0256-4947.2015.231","article-title":"Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage","volume":"35","author":"Bafaqih","year":"2015","journal-title":"Ann. Saudi Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108187_bib14","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6887.1000171","article-title":"Systematic review of tranexamic acid adverse reactions","volume":"3","author":"Calapai","year":"2015","journal-title":"J. Pharmacovigil."},{"issue":"2","key":"10.1016\/j.rmed.2025.108187_bib15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108187_bib16","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2025.108187_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1378\/chest.128.2.729","article-title":"Massive hemoptysis in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108187_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ppul.1950150311","article-title":"Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis","volume":"15","author":"Schidlow","year":"1993","journal-title":"Pediatr. Pulmonol."},{"issue":"6","key":"10.1016\/j.rmed.2025.108187_bib19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2025.108187_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jcpt.13463","article-title":"A role for nebulized tranexamic acid in veno-venous ECMO patients","volume":"47","author":"Cabanilla","year":"2022","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"5","key":"10.1016\/j.rmed.2025.108187_bib21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.chest.2022.11.021","article-title":"Nebulized vs IV tranexamic acid for hemoptysis: a pilot randomized controlled trial","volume":"163","author":"Gopinath","year":"2023","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2025.108187_bib22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.chest.2019.02.010","article-title":"Antifibrinolytic agents for hemoptysis management in adults with cystic fibrosis","volume":"155","author":"Al-Samkari","year":"2019","journal-title":"Chest"},{"year":"2020","series-title":"Australian Product Information Cyklokapron\u00ae (Tranexamic Acid)","key":"10.1016\/j.rmed.2025.108187_bib23"},{"issue":"1","key":"10.1016\/j.rmed.2025.108187_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.ccm.0000729940.79996.16","article-title":"Acute airway obstruction due to endotracheal clot following inhaled tranexamic acid","volume":"49","author":"Espinosa","year":"2020","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108187_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1099-0496(199704)23:4<249::AID-PPUL2>3.0.CO;2-H","article-title":"Effect of nebulizer type and antibiotic concentration on device performance","volume":"23","author":"Weber","year":"1997","journal-title":"Pediatr. Pulmonol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108187_bib27","first-page":"211","article-title":"Simply, inhaled aerosols can cause bronchoconstriction and cough, but absence of a permeant ion causes cough alone","volume":"129","author":"Eschenbacher","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2025.108187_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00228-024-03784-5","article-title":"Advances in the study of nebulised tranexamic acid for pulmonary hemorrhage","volume":"81","author":"Zhang","year":"2025","journal-title":"Eu J Clin Pharma"},{"issue":"1","key":"10.1016\/j.rmed.2025.108187_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12245-020-00304-x","article-title":"Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series","volume":"13","author":"Alabdrabalnabi","year":"2020","journal-title":"Int. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108187_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.chest.2019.02.018","article-title":"Tranexamic acid: emerging therapies in hemoptysis","volume":"155","author":"Bharath","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2025.108187_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.08.1179","article-title":"Inhaled tranexamic acid in vasculitis-induced massive hemoptysis","volume":"156","author":"Modi","year":"2019","journal-title":"Chest"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:32:24Z","timestamp":1764919944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125002495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"alternative-id":["S0954611125002495"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108187","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of nebulised tranexamic acid in adult patients with cystic fibrosis: A retrospective audit","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108187"}}